The presentation will be held at the EIPBN conference - 65th International Conference on Electron, Ion and Photon Beam Technology and Nanofabrication,
which will take place between May 31 and June 3, 2022, in New Orleans, Louisiana.
The Sofusa® Drug Delivery System, for which Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles, was highlighted in Sorrento Therapeutics proprietary mRNA vaccine development program for COVID-19.
Sorrento Therapeutics, a biopharmaceutical company, reports positive initial result in dosing with the Sofusa® Lymphatic Drug Delivery Device. Sorrento Therapeutics use Obducat’s NIL technology to fabricate the nanotopography draped microneedles used in the Sofusa® Drug Delivery System.
Obducat is an innovative developer and world-leading supplier of micro-and nano lithography solutions. We supply the technology, products and processes used for advanced micro- and nanopatterning of surfaces.
Obducat receives order for production service to a value of approximately SEK 1.2 million
OBDUCAT AB (publ) subsidiary Obducat Technologies AB, a leading supplier of lithography solutions based on Nanoimprint Lithography (NIL), has received an order from a customer concerning production service. The order value amounts to approximately SEK 1.2 million. The customer is a European player in the field of functional films and the order refers to the…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.